Immix Biopharma Stock Widgets and Gadgets
| IMMX Stock | USD 1.70 0.13 7.10% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- IMMX Immix Biopharma
- Latest Immix Biopharma Projected to Post Quarterly Earnings on Thursday - Defense World
- IMMX 1.7 -0.13
- Low 1.66
- High 1.8
- Volume 24.2 K
- Alpha -0.13
- Beta 0.0191
- Return On Equity -1.47
- Return On Asset -0.66
- Current Valuation 33.73 M
- Shares Outstanding 27.51 M
- Shares Owned By Insiders 39.78 %
- Shares Owned By Institutions 12.10 %
- Number Of Shares Shorted 389.44 K
- Price To Book 3.80 X
- EBITDA (22.67 M)
- Net Income (21.7 M)
- Cash And Equivalents 18.4 M
- Cash Per Share 1.32 X
- Total Debt 1.07 M
- Debt To Equity 0 %
- Current Ratio 19.53 X
- Book Value Per Share 0.48 X
- Cash Flow From Operations (14.6 M)
- Short Ratio 6.52 X
- Earnings Per Share (0.71) X
- Target Price 7.0
- Beta 0.25
- Market Capitalization 50.34 M
- Total Asset 22.95 M
- Retained Earnings (75.02 M)
- Working Capital 11.51 M
- Net Asset 22.95 M
- Accumulation Distribution 1878.88
- Daily Balance Of Power (0.93)
- Rate Of Daily Change 0.93
- Day Median Price 1.73
- Day Typical Price 1.72
- Price Action Indicator (0.1)
- Period Momentum Indicator (0.13)
- Relative Strength Index 48.6
Market Snapshot Widget Example
DAX Index Germany | 22,462 0.96 | |
Taiwan Weighted Taiwan | 21,603 1.59 | |
PSI 20 Stock Portugal | 6,951 0.75 | |
CROBEX Croatia | 3,329 0.11 | |
Budapest SE Hungary | 91,416 1.41 | |
IDX 30 Jakarta Indonesia | 386.86 0.42 | |
ISEQ 20 Price Ireland | 1,760 1.45 | |
NYSE Comp USA | 19,270 1.35 | |
Tel Aviv 35 Israel | 2,461 0.89 | |
Coreshares Index Tracker South Afric | 1,108 1.95 | |
IPC MEXICO Mexico | 53,173 0.57 | |
KL Technology Malaysia | 50.27 1.32 | |
IBEX 35 Index Spain | 13,309 0.84 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 4,176 2.08 | |
SPASX Dividend Opportunities Australia | 1,661 0.80 | |
HNX 30 Vietnam | 502.01 1.15 | |
Bucharest BET-NG Romania | 1,262 0.07 | |
AMS Small Cap Netherlands | 1,381 0.78 | |
Oslo Exchange Mutual Norway | 1,463 1.34 | |
BEL Small Belgium | 8,418 0.15 | |
Basic Materials Brazil | 5,422 1.55 | |
Swiss Leader Price Switzerland | 2,077 0.28 | |
Fondo Mutuo ETF Chile | 1,563 0.48 | |
Athens General Comp Greece | 1,736 0.6 | |
Stock Exchange Of Thailand | 1,175 1.05 | |
PX Prague Stock Czech Repub | 2,145 0.37 | |
THE PHILIPPINE STOCK Philippines | 6,147 0.13 | |
WIG 30 Poland | 3,505 1.04 | |
BIST Electricity Turkey | 465.96 1.39 |
Investing Ideas
In addition to having Immix Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Immix Biopharma
Compare Immix Biopharma To Peers
Additional Tools for Immix Stock Analysis
When running Immix Biopharma's price analysis, check to measure Immix Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immix Biopharma is operating at the current time. Most of Immix Biopharma's value examination focuses on studying past and present price action to predict the probability of Immix Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immix Biopharma's price. Additionally, you may evaluate how the addition of Immix Biopharma to your portfolios can decrease your overall portfolio volatility.